Adverse drug reactions in a department of systemic diseases-oriented internal medicine: Prevalence, incidence, direct costs and avoidability

European Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2000, Pages 181-186

  Lagnaoui, R ^a   Moore, N ^a   Fach, J ^b   Longy Boursier, M ^b   Begaud B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Adverse drug reactions; Costs; Hospital

Indexed keywords

ANESTHETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; DIURETIC AGENT; IMMUNOLOGIC AGENT; NEUROLEPTIC AGENT;

ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; NEUROLOGIC DISEASE; OSTEOMALACIA; PRIORITY JOURNAL; SKIN MANIFESTATION; SYSTEMIC DISEASE;

EID: 0034038635     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050738     Document Type: Article

References (30)

1. 1. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27: 832-840
2. 2. Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266: 2847-2851
3. 3. Hallas J, Harvald B, Worm J, Beck-Nielsen J, Gram LF, Damsbo N, et al. (1993) Drug-related hospital admission. Results from an intervention program. Eur J Clin Pharmacol 45: 199-203
4. 4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. (1997) The costs of adverse drug events in hospitalized patients. JAMA 277: 307-311
5. 5. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277: 301-306
6. 6. Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45: 301-308
7. 7. Directive 93/39/EC and Regulation 2309/93/EC (1993) Commission of the European communities, Brussels
8. 8. International Conference on Harmonisation (ICH) (1994) ICH topic E2a: clinical safety data management: definitions and standards for expedited reporting. International Federation of Pharmaceutical Manufacturers Association (IFPMA) http:// www.pharmaweb.net/pwmirror/pw9/ifpma/ich5.html; reference number CPMP/ICH/377/95
9. 9. Dubois RW, Brook RH (1988) Preventable deaths: who, how, often and why? Ann Intern Med 190: 582-589
10. 10. Centers for Diseases Control and World Health Organization (1997) EPI-INFO, version 6.04 fr Centers for Diseases Control, USA, and World Health Organization, Geneva, Switzerland
11. 11. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, et al. (1990) Drug-related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228: 83-90
12. 12. Chan TY, Chan JC, Tomlinson B, Critcheley JA (1992) Adverse reactions to drugs as a cause of admissions to a general teaching hospital in Hong Kong. Drug Saf 7: 235-240
13. 13. Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150: 841-845
14. 14. Garijo B, de Abajo FJ, Castro MA, Lopo CR, Carcas A, Frias J (1991) Hospitalizations because of drugs: a prospective study. Rev Clin Esp 188: 7-12
15. 15. Hallas J, Davidsen O, Grodum E, Damsbo N, Gram LF (1992) Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration 59: 30-34
16. 16. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N (1990) Drug-related admissions to a cardiology department: frequency and avoidability. J Intern Med 228: 379-384
17. 17. Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF (1991) Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol 26: 174-180
18. 18. Hallas J, Worm J, Beck-Nielsen J, Gram LF, Grodum E (1991) Drug-related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 38: 417-420
19. 19. Lin SH, Lin MS (1993) A survey on drug-related hospitalization in a community teaching hospital. Int J Clin Pharmacol Ther Toxicol 3: 66-69
20. 20. Lindley CM, Tully MP, Paramsothy V, Tallis RC (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 2: 294-300
21. 21. Smucker WD, Kontak JR (1990) Adverse drug reactions causing hospital admission in an elderly population: experience with a decision algorithm. J Am Board Fam Pract 3: 105-109
22. 22. Van Kraaij DJ, Haagsma CJ, Go IH, Gribnau FW (1994) Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 44: 166-173
23. 23. Imbs JL, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac JP, Bégaud B et le réseau des centres régionaux de Pharmacovigilance (1999) Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie 54: 21-27
24. 24. Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Drug-related hospital admissions in France: a multicentre incidence study in medical departments. BMJ (in press)
25. 25. Carbonin P, Pahor M, Bernabei R, Sgadari A (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39: 1093-1099
26. 26. Forman MD, Theis SL, Anderson MA (1993) Adverse events in the hospitalized elderly. Clin Nurs Res 2: 360-370
27. 27. O'Neil AC, Petersen LA, Cook EF, Bates DW, Lee TH, Brennan TA (1993) Physician reporting compared with medical record review to identify adverse medical events. Ann Intern Med 119: 370-376
28. 28. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. (1995) Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 274: 29-34
29. 29. Moore N, Briffaut C, Noblet C, Normand CA, Thuillez C (1995) Indirect drug-related costs. Lancet 345: 588-589
30. 30. Dartnell JG, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, et al. (1996) Hospitalization for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 164: 659-662